{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions f"],"components":["Active, inactive f"],"effective_time":"20190510","id":"888a969b-95de-296c-e053-2995a90afa24","instructions_for_use":["Directions for use ds"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-5071-3 DIBUCAINE HCL USP 0.5% / LIDOCAINE USP 15% / PHENYLEPHRINE HCL USP 1% / PRILOCAINE USP 5%. Ointment 120gm s"],"set_id":"888a969b-95dd-296c-e053-2995a90afa24","spl_product_data_elements":["DIBUCAINE HCL 0.5% / LIDOCAINE 15% / PHENYLEPHRINE HCL 1% / PRILOCAINE 5% DIBUCAINE HCL 0.5% / LIDOCAINE 15% / PHENYLEPHRINE HCL 1% / PRILOCAINE 5% DIBUCAINE HYDROCHLORIDE DIBUCAINE PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE LIDOCAINE LIDOCAINE PRILOCAINE PRILOCAINE"],"version":"1"}